Delivery Order SPE2DB24D1021-SPE2DB25FEXEY
- Not listed
- The Defense Logistics Agency awarded a $1,777.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 12 mg tablets (30-count units), with a completion deadline of June 2, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,027.44 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count) on August 14, 2025, with completion targeted for August 15, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,149.54 to AmerisourceBergen Drug Corp for FYCOMPA 4 mg tablets (30-count packaging) on June 18, 2025, with completion targeted for June 20, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive...
- The Defense Logistics Agency awarded a $2,067.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 MG tablets (30-count packaging) on July 10, 2025, with completion expected by July 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,891.67 to AmerisourceBergen Drug Corp for FYCOMPA (perampanel) 8 mg tablets, a 30-count supply. This contract was competitively awarded without set-aside designation and is categorized as a firm fixed price delivery order, with an ultimate completion date of October 20, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,027.44 for Fycompa 8 mg tablets (30-count) with an ultimate completion date of September 5, 2025. This competitive delivery order, issued under firm fixed-price terms with no set-aside designation, represents a single pharmaceutical supply transaction fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,524.73 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition for this...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of FYCOMPA 12 mg tablets (30-count) with a contract value of $1,051.80. The award is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.80 Firm Fixed Price Delivery Order contract has an ultimate completion date of April 10, 2025 and is not designated with a set-aside. The contract provides for the delivery of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for Fycompa 8 mg tablets (30-count units) with a ceiling value of $1,713.96. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, represents a continuation of AmerisourceBergen's significant role as a pharmaceutical supplier to the federal government. The award was made without a set-aside designation, indicating open competition. The performance location is...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXEYDelivery Order
The Defense Logistics Agency awarded a $1,457.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 mg tablets (30-count packaging) with a completion date of June 2, 2025. This non-set-aside competitive award represents a single delivery order placed against AmerisourceBergen's broader pharmaceutical supply contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver pharmaceutical products to support federal medical procurement needs. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems and other federal customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor, has demonstrated consistent capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains, positioning it as a critical vendor within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/30/25 |